세계 재조합 단백질 시장 규모는 2023년 1,324억 달러에서 예측 기간 동안 7.5%의 CAGR로 2029년에는 2,036억 달러에 달할 것으로 예상됩니다.
북미는 2023년 502억 달러에서 연평균 6.7% 성장하여 2029년에는 743억 달러에 달할 것으로 예상됩니다. 아시아태평양은 2023년 303억 달러에서 연평균 9.2% 성장하여 2029년에는 507억 달러에 달할 것으로 예상됩니다.
세계 재조합 단백질 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 신흥 기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
발현 숙주 시스템 종류
재조합 단백질 작용기서
작용제
길항제
재조합 단백질 생산의 일반적인 절차
제3장 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
제4장 신기술과 개발
개요
신기술
단백질 엔지니어링의 진보
CRISPR 유전체 편집
무세포 단백질 합성
제5장 시장 세분화 분석
세분화 내역
세계의 재조합 단백질 시장 : 제품 유형별
호르몬
시장 규모와 예측
사이토카인
시장 규모와 예측
효소
시장 규모와 예측
항체
시장 규모와 예측
항원
시장 규모와 예측
기타
시장 규모와 예측
세계의 재조합 단백질 시장 : 숙주 세포 유형별
세균 숙주 세포
시장 규모와 예측
효모와 진균 세포
시장 규모와 예측
포유류 세포
시장 규모와 예측
곤충 세포
시장 규모와 예측
기타
시장 규모와 예측
세계의 재조합 단백질 시장 : 용도별
치료제와 백신
시장 규모와 예측
바이오 의료 연구
시장 규모와 예측
진단
시장 규모와 예측
지역적 내역
세계의 재조합 단백질 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제6장 경쟁 정보
경쟁 상황
M&A 분석
임상시험 활동
제7장 재조합 단백질 시장의 ESG의 관점
재조합 단백질 시장의 지속가능성
ESG 데이터 이해
환경 퍼포먼스
사회적 퍼포먼스
지배구조 퍼포먼스
BCC의 결론
제8장 부록
조사 방법
정보 출처
두문자어
기업 개요
AMGEN INC.
BAYER AG
F. HOFFMANN-LA ROCHE LTD.
LILLY
MERCK KGAA
NOVO NORDISK A/S
PFIZER INC.
SANDOZ GROUP AG
SANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
ksm
영문 목차
영문목차
The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.
The North American market for recombinant proteins is estimated to increase from $50.2 billion in 2023 to reach $74.3 billion by 2029, at a CAGR of 6.7% from 2024 through 2029.
The Asia-Pacific market for recombinant proteins is estimated to increase from $30.3 billion in 2023 to reach $50.7 billion by 2029, at a CAGR of 9.2% from 2024 through 2029.
Report Scope
This report covers the current and future global market for recombinant proteins, including a detailed analysis of the market's drivers, restraints and opportunities. The report also covers market projections for 2029, the market's competitive environment and companies' pipeline activities. The report delivers market estimates and forecasts for recombinant proteins categorized according to product type, host cell type, application, and region. Based on product type the market is segmented into hormones, cytokines, enzymes, antigens, antibodies, and others. Based on the host cell type, recombinant proteins are categorized as mammalian, insect, yeast and fungi, bacterial, and other cell types. The market is segmented by application into therapeutics and vaccines, biomedical research, and diagnostics. The report includes the company profiles of the key players, with detailed information about their business segments, financials, product portfolios, and recent developments. The report does not cover proteins produced through hybridoma techniques. The report also excludes COVID-19 vaccines based on recombinant technology.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Regional analysis is further broken down by country as follows: North America-the U.S. and Canada; Europe-Germany, the U.K., France, Italy, and the Rest of Europe; Asia-Pacific-China, Japan, India, and the Rest of Asia-Pacific. For market estimates, data have been provided for 2021 and 2022 as the historic years, 2023 as the base year, and a forecast through 2029.
Report Includes
45 data tables and 46 additional tables
Analysis of the global market for recombinant proteins
Analyses of the global market trends, with market revenue data for 2022, estimates for 2023, forecasts for 2024 and projected CAGRs through 2029
Discussion of the market drivers, restraints and opportunities
Estimate of the current market size and revenue prospects, along with a market share analysis by product (protein type), host cell type, application and region
Facts and figures pertaining to the market dynamics, current and emerging technologies, regulatory scenario, and the expected impact of macroeconomic factors
Overview of sustainability and ESG trends, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
Analysis of recent patents and pipeline activity
A look at the industry structure, including companies' market shares, M&A activity and venture funding
Company profiles of major players within the industry, including Novo Nordisk A/S, Lilly, Sanofi, and Amgen Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Types of Expression Host Systems
Mechanism of Action of Recombinant Proteins
Agonists
Antagonists
Common Steps Involved in Recombinant Protein Production
Chapter 3 Market Dynamics
Drivers
Growing R&D Investments in Biopharmaceuticals
Increasing Demand for Non-Hybridoma Techniques
Restraints
High Production Costs
Post-Translational Modifications and Protein Stability
Opportunities
Diagnostic and Therapeutic Applications of Recombinant Antibodies
Continuous Manufacturing and Improving Product Yields
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
Protein-Engineering Advances
CRISPR Genome Editing
Cell-Free Protein Synthesis
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Recombinant Proteins, by Product Type
Hormones
Market Size and Forecast
Cytokines
Market Size and Forecast
Enzymes
Market Size and Forecast
Antibodies
Market Size and Forecast
Antigens
Market Size and Forecast
Others
Market Size and Forecast
Global Market for Recombinant Proteins, by Host Cell Type
Bacterial Host Cells
Market Size and Forecast
Yeast and Fungi Cells
Market Size and Forecast
Mammalian Cells
Market Size and Forecast
Insect Cells
Market Size and Forecast
Other Cells
Market Size and Forecast
Global Market for Recombinant Proteins, by Application
Therapeutics and Vaccines
Market Size and Forecast
Biomedical Research
Market Size and Forecast
Diagnostics
Market Size and Forecast
Geographic Breakdown
Global Market for Recombinant Proteins, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Competitive Landscape
M&A Analysis
Clinical Trial Activities
Chapter 7 ESG Perspective in the Recombinant Proteins Market
